Contribute Try STAT+ Today

Amid a contentious bankruptcy court trial, a member of the Sackler family that owns Purdue Pharma said they would not proceed with plans to contribute more than $4.3 billion to settle massive litigation over the opioid crisis unless they are granted immunity from all existing and future legal claims.

David Sackler, 41, who is a former Purdue board member and grandson one of the founders of the drug maker, acknowledged the family has a “moral responsibility to try and help, and that’s what this settlement is designed to do.” But he also maintained that without receiving a global release from legal liability, the carefully crafted settlement would fall apart.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment